ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04512	ECM-receptor interaction	9/41	79/7206	3.7878498965e-10
ko04510	Focal adhesion	10/41	240/7206	6.29250984502e-07
ko04974	Protein digestion and absorption	7/41	96/7206	9.2781645621e-07
ko04151	PI3K-Akt signaling pathway	11/41	390/7206	7.34199203664e-06
ko04640	Hematopoietic cell lineage	5/41	64/7206	2.76233112636e-05
ko05146	Amoebiasis	5/41	99/7206	0.000223914876002
ko05222	Small cell lung cancer	4/41	89/7206	0.00155355027546
ko05410	Hypertrophic cardiomyopathy (HCM)	4/41	100/7206	0.00238512838856
ko05414	Dilated cardiomyopathy	4/41	112/7206	0.00359686835833
ko05205	Proteoglycans in cancer	6/41	271/7206	0.00397269561707
ko05145	Toxoplasmosis	4/41	126/7206	0.00547434048778
ko05200	Pathways in cancer	8/41	492/7206	0.00574286907601
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3/41	79/7206	0.010023355534
ko00030	Pentose phosphate pathway	2/41	32/7206	0.0140647449475
ko04060	Cytokine-cytokine receptor interaction	4/41	191/7206	0.0225537624407
ko04933	AGE-RAGE signaling pathway in diabetic complications	3/41	135/7206	0.0408697435843
ko04916	Melanogenesis	3/41	142/7206	0.0463431738466